GT Biopharma (GTBP) Other financing activities (2011 - 2026)
GT Biopharma (GTBP) posted quarterly Other financing activities of $577000.0 for Q1 2026, down 6.33% year-over-year from $616000.0 in Q1 2025, and down 87.02% quarter-over-quarter from $4.4 million in Q4 2025.
GT Biopharma (GTBP) Other financing activities (2011 - 2026) Analysis & Trends
GT Biopharma (GTBP) has reported Other financing activities for 7 consecutive years, with $577000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities fell 6.33% year-over-year to $577000.0; the TTM figure through Mar 2026 stood at $5.5 million (down 67.88% YoY), while the FY2025 annual figure was $5.5 million, changed N/A from the prior year.
- Other financing activities retreated to $577000.0 in Q1 2026 per GTBP's latest filing, from $4.4 million in the prior quarter.
- Across five years, Other financing activities topped out at $4.4 million in Q4 2025 and bottomed at $436000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GT Biopharma | 8.64 Mn | 8.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 577,000.00 |
| Mar 31, 2026 | 577,000.00 |
| Dec 31, 2025 | 4.44 Mn |
| Dec 31, 2025 | 4.44 Mn |
| Jun 30, 2025 | 436,000.00 |
| Jun 30, 2025 | 436,000.00 |
| Mar 31, 2025 | 616,000.00 |
| Mar 31, 2025 | 616,000.00 |
| Sep 30, 2021 | 137,000.00 |
| Sep 30, 2021 | 137,000.00 |
| Jun 30, 2021 | 16.24 Mn |
| Jun 30, 2021 | 16.24 Mn |
| Mar 31, 2021 | 58,000.00 |
| Mar 31, 2021 | 58,000.00 |
| Dec 31, 2014 | -19,000.00 |
| Dec 31, 2014 | -19,000.00 |
| Sep 30, 2014 | 1,000.00 |
| Sep 30, 2014 | 1,000.00 |
| Jun 30, 2014 | 1,000.00 |
| Jun 30, 2014 | 1,000.00 |